Assessment of Concordant Human Papillomavirus Infection With 9-Valent Vaccine Types Across Anogenital Sites in Young Men
Concordant anogenital 9vHPV infection was more common among MSM than HM, which is consistent with evidence that MSM are at increased risk of HPV-related cancer across multiple anogenital sites. Clinical Trial Registration: ClinicalTrials.gov, NCT00090285.
Authors
- Stephen E. Goldstone (ORCID: https://orcid.org/0000-0001-7585-3508)
- Georges J. Nahhas (ORCID: https://orcid.org/0000-0001-8909-2228)
- Cara J. Broshkevitch (ORCID: https://orcid.org/0000-0002-5627-8250)
- Alfred J. Saah
- Christine Velicer
- Joseph E. Tota (ORCID: https://orcid.org/0000-0003-1941-7685)
- Alain Luxembourg
- Anna R. Giuliano (ORCID: https://orcid.org/0000-0002-5440-8859)
- Joel M. Palefsky (ORCID: https://orcid.org/0000-0002-5097-3818)
- Brady Dubin
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of California, San Francisco (US)
- Moffitt Cancer Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1093/infdis/jiaf564
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00